BRCA2 and neoplasm: When these genes were identified, it soon became clear that breast cancer in women with pathogenic mutations in BRCA1 had worse prognostic features compared with women carrying pathogenic BRCA2 mutations who have tumours more reflective of breast cancer in the general population although still with a marginally increased level of high grade tumours [1–3].